30-40% of COVID-19 cases appear asymptomatically and some symptoms of COVID-19 can be mistaken for other respiratory diseases such as influenza.
In combination with vaccination, many experts suggest that COVID-19 rapid testing can assist safer business reopens.
Most current rapid testing is based on lateral flow methodology. Lateral flow COVID-19 testing is known for its low sensitivity during the early stage of COVID-19. Consequently, false results may lead to delayed interventions and increased local transmissions.
In contrast, SeraParma™ COVID-19 IgM Testing is as sensitive as the gold standard RT-PCR testing. SeraParma™ test results are returned from a finger prick drop of blood in only 20 minutes.
Businesses can reopen safely after individuals have received a negative test result before entering their workplaces or areas for social gathering.